Ligand validation:4HGG

SYN: ethenylbenzene

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4HGG_SYN_A_502	52%	12%	0.137	0.895	2.43	1.62	2	1	5	0	100%	1
4HGG_SYN_B_502	41%	16%	0.15	0.866	2.61	1.13	2	1	1	0	100%	1
4HGF_SYN_A_502	51%	29%	0.133	0.888	2	0.89	2	-	3	0	100%	1
4HGH_SYN_A_502	50%	36%	0.095	0.844	1.69	0.84	2	-	0	0	100%	1
7WDE_SYN_A_506	38%	68%	0.168	0.871	0.57	0.67	-	-	0	0	100%	1
4HGI_SYN_B_503	35%	24%	0.187	0.876	1.8	1.33	2	1	10	0	100%	0.5
6R3L_SYN_A_606	86%	21%	0.093	0.962	1.4	1.87	2	2	2	0	100%	0.4

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.